StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.15−0.39 (-4.57%)

Close on Nov 17, 2026Market cap $284.29MP/E –Yield –

Benitec Biopharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Benitec Biopharma's pe ratio was 179.1× on Jul 31, 2020.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2020Jul 31, 2020179.1×−12.8
2019Dec 31, 2019191.9×–

More Benitec Biopharma figures

See a number that looks wrong?